CLINICAL_TRIALS ClinicalTrials.gov record update

Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparation of Cephalexin 125 mg/ 5 ml (Ceporex® GlaxoSmithKline México, S.A. de C.V. vs. Keflex®, Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01767532
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:32.099066+00:00
Published At: 2017-06-22T00:00:00+00:00
Record Updated At: 2017-06-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Respiratory Tract"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-06-22"
protocolSection.identificationModule.nctId: "NCT01767532"
protocolSection.identificationModule.officialTitle: "Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparation of Cephalexin 125 mg/ 5 ml (Ceporex\u00ae GlaxoSmithKline M\u00e9xico, S.A. de C.V. vs. Keflex\u00ae, Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V.) in Fasting Healthy Volunteers"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.